Caisson Biotech, a leader in half-life extension and drug delivery, has established a global manufacturing partnership with CordenPharma, a full-service contract development and manufacturing organization (CDMO) manufacturing APIs and drug products through a network of cGMP facilities across Europe and the U.S. Caisson has demonstrated successful technology transfer and cGMP scale-up with its corporate pharmaceutical partners utilizing its patented heparosan-based half-life extension and drug...